| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $4.2M | -10.9% | +46.9% |
| SG&A Expense | $649K | -26.6% | +17.8% |
| Operating Income | -$4.8M | +13.4% | -42.2% |
| Pre-tax Income | -$4.8M | +13.4% | -42.2% |
| Income Tax | $863 | +1.5% | — |
| Net Income | -$4.8M | +13.4% | -42.2% |
| EPS (Basic) | -$0.13 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.6M | +23.5% | -9.5% |
| Current Assets | $2.0M | +36.7% | -9.5% |
| Total Assets | $3.5M | +18.2% | -5.7% |
| Current Liabilities | $13.4M | +47.2% | +347.0% |
| Total Liabilities | $13.4M | +47.2% | +347.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | +27.5% |
| Financing Cash Flow | $2.3M | — | +1640.5% |
| +13.3% |
| -44.4% |
| EPS (Diluted) | -$0.13 | +13.3% | -44.4% |
| -$9.8M |
| -61.4% |
| -1418.1% |